AIML.CN up 14.29% to C$0.04 on CNQ: AI/ML Innovations Inc. 16 Feb 2026 outlook

AI/ML Innovations Inc. (AIML.CN) rose 14.29% to C$0.04 during market hours on 16 Feb 2026, driven by small-volume trading and renewed AI interest. The stock trades on the CNQ exchange in Canada with a market cap of C$6,730,560.00 and 15,000 shares changing hands today. Investors focused on AI stocks should weigh AIML.CN stock’s early-stage digital healthcare product set against thin liquidity and a negative EPS of -0.03 per share. This note gives a concise view of valuation, technicals, sector context, the proprietary Meyka grade, and a model-based forecast for AIML.CN stock.

AIML.CN stock: Quick snapshot and market moves

AI/ML Innovations Inc. (AIML.CN) is trading at C$0.04 with a day range of C$0.04-C$0.04 and a year high of C$0.12. The company shows a one-day change of 14.29% and YTD change of 14.29%, but average daily volume is thin at 392,171.00 shares versus today’s 15,000.00. The stock’s EPS is -0.03 and the trailing PE is negative at -1.33, reflecting ongoing losses. Traders should note the price averages: 50-day C$0.04 and 200-day C$0.05, which signals limited recent momentum.

AIML.CN stock: Fundamentals and valuation

AIML.CN stock posts weak fundamentals: price-to-sales is 40.00, price-to-book is 5.23, and return-on-equity is -3.31%, indicating high valuation vs. tiny revenue per share of C$0.00 (0.00079). The balance sheet shows C$0.01 cash per share and a current ratio of 2.09, which gives short-term flexibility. Net income per share is -0.03 and free cash flow per share is -0.03, so the company is not cash-generative. These metrics point to speculative value typical of small AI healthcare plays.

AIML.CN stock: Technicals, liquidity and risk

Momentum indicators are muted: RSI is 40.70, ADX 14.53 (no trend), and MACD is flat, so technical conviction is low. Average volume over 50 days is 392,171.00 while today’s traded volume is 15,000.00, creating elevated liquidity risk and wide potential bid-ask spreads. Volatility measures such as Bollinger Bands narrow around C$0.04, but low liquidity can cause sharp intraday moves. For active AI stock traders, small-cap execution risk is a primary consideration.

AIML.CN stock: Sector context and competitive risks

AI/ML Innovations operates in Healthcare digital services, a sector with average ROE near 19.58% and mixed short-term performance; AIML.CN’s profitability lags sector peers. Broader AI headlines can help sentiment for AIML.CN stock, but healthcare regulation and adoption cycles pose product risk. Reuters tracks AI developments that influence investor appetite for AI stocks; see Reuters’ AI coverage for wider trends source. Competition from larger healthcare IT players raises execution and commercialization risk for AIML.CN.

AIML.CN stock: Meyka grade and model forecast

Meyka AI rates AIML.CN with a score out of 100: 62 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly price of C$0.02 and a monthly level of C$0.01, compared with the current C$0.04, implying model-based downside. These forecasts are model-based projections and not guarantees; they signal caution for value-seeking AI stock investors.

AIML.CN stock: Strategy for AI growth investors

For AI-focused investors, AIML.CN stock fits a high-risk, optionality-only sleeve of a portfolio because of negative earnings and limited liquidity. Consider position sizing limits and an exit plan: a conservative base target is C$0.04, a bullish scenario aligns to the year high C$0.12, and a downside stress case is C$0.02. Monitor quarterly updates, product milestones, cash runway, and sector AI headlines that drive flow into small caps. Use stop-losses and keep exposure under a small percentage of total equity when trading tiny AI healthcare names.

Final Thoughts

Key takeaway: AIML.CN stock trades at C$0.04 on the CNQ exchange in Canada with significant liquidity and profitability risks, and a market cap of C$6,730,560.00. Meyka AI rates AIML.CN 62/100 (B, HOLD) and highlights weak fundamentals including negative EPS -0.03, high price-to-sales 40.00, and thin average volume 392,171.00. Meyka AI’s forecast model projects a yearly price of C$0.01958, which implies a -51.05% move from the current C$0.04; monthly projection is C$0.01, implying -75.00%. Forecasts are model-based projections and not guarantees. For AI stock strategies, treat AIML.CN as a speculative, news-driven play: size positions tightly, track product or regulatory milestones, and prioritize capital preservation. If you prefer upside with less execution risk, consider larger AI healthcare names instead. This analysis uses market data, sector context, and the Meyka AI model to frame a risk-aware view on AIML.CN stock.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.